Meredith P. Riebschleger, M.D., M.S.
Clinical Lecturer, Department of Pediatrics and Communicable Diseases, Pediatric Rheumatology
Dr. Riebschleger's research focuses on identifying and improving different mechanisms of health care delivery to stretch the reach of the limited pediatric subspecialty workforce. She is especially interested in the use of patient/parent reported outcomes and telemedicine for children who live far away from academic medical centers like the University of Michigan.
Dr. Riebschleger's clinical interests include the care of children with all forms of rheumatologic diseases.
M.S., Health and Health Services Research, University of Michigan, 2012
M.D., Drexel University College of Medicine, 2005
B.S., Biology, University of Notre Dame, 2001
Noncompletion in pediatric rheumatology fellowships.
J Grad Med Educ. 2014 Mar;6(1):158-61.
AMIGO: a novel approach to the mentorship gap in pediatric rheumatology.
J Pediatr. 2014; 164(2):226-227.
Meta-analysis: rapid infliximab infusions are safe.
Alimentary Pharmacology and Therapeutics. 2013;38(4):365-376.
Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis.
Arthritis Care and Research 2013;65(5):745-52.